Quest Diagnostics Incorporated (DGX) earnings on July 23, 2026

Before the market opens Q2 2026

More Quest Diagnostics Incorporated earnings

Prior outlook: Optimistic Outcome: Accurate

Quest Diagnostics stock jumped after reporting strong earnings, driven by higher demand for preventive health tests.

DGX price around the earnings

227.90

Change: +8.6%

2026-07-23, 20:00 UTC

Start of the measured window End of the measured window
209.83 218.17 226.52 234.86 209.83
Price series around the eventClosing price per minute from before the event to the end of the measured window.
July 23, 2026
  • Price: green if it ends above the starting price; red if it ends below
  • Start of the measured window
  • End of the measured window
  • Market open
  • Starting price
Price series around the event

Prior thesis

Prior outlook: Optimistic Outcome: Accurate

Thesis published
Results released

Pre-release: Strong product approval and historical beats, with positive trend strength building into earnings.

Context analyzed before publication

Trend
Consistent positive scores with recent acceleration, indicating a moderate run-up into the earnings event.

Analysts

Evidence

Analyst consensus
Buy
Consensus average (1-5)
2.17
Analysts covering the stock
16
Average price target
223.94
Lowest price target
184
Highest price target
245
Upside to price target
6.7%
Quarterly earnings growth
14.5%
Revenue growth
9.2%
Forward EPS
11.67
Trailing EPS
9.19
Analyst moves in the last 60 days
1
  • July 13, 2026 · Baird: Maintains rating (Neutral → Neutral)

News and sentiment

Evidence

Sentiment
Sentiment
Neutral
Mentions
0
News
Sources (2)

Technicals

Evidence

Average true range (ATR)
2.3%
Distance to 52-week high
-2.5%
14-day change (14d)
+1.1%
30-day change (30d)
+8.7%
30-day relative strength
+8.3%
SPY change (30d)
+0.4%
Nearest support
209.66
Nearest resistance
210.84
Volume accumulation ratio (14d / 46d)
1.16

Trends

Evidence

Average earnings surprise
+3.5%
  • April 21, 2026: actual EPS 2.5 vs estimate 2.37 (surprise +5.6%)
  • February 10, 2026: actual EPS 2.42 vs estimate 2.36 (surprise +2.6%)
  • October 21, 2025: actual EPS 2.6 vs estimate 2.5 (surprise +3.9%)
  • July 22, 2025: actual EPS 2.62 vs estimate 2.57 (surprise +1.9%)

Expected move

Implied move
+2.0%
Source
Options chain

Reactions over its last 20 earnings

Median move
4.1%
75th percentile move
5.9%
90th percentile move
6.8%
Up / down moves
12 / 8
Average up move
+4.6%
Average down move
-2.7%

Monitoring and close

What Quest Diagnostics Incorporated reported

Status
Finished
Actual EPS3.12
EPS estimate2.83
EPS surprise+10.2%
Revenue$3,043 million
Revenue estimate$2,973 million
Revenue surprise+2.4%

Quest Diagnostics beats Q2 2026 estimates and raises full-year guidance. Shares surge 6.7% on strong results and optimistic outlook.

Sources (18)

Pre-market second reading after the results

Verdict
Beat expectations

Heading into the open, the figures confirm the optimistic scenario. In the 1037 past cases with a similar move, the close held that direction 96% of the time.

How the stock reacted

Outcome
Accurate
Consolidated
+8.6%
Max favorable move (MFE)
13.3%
Max adverse move (MAE)
0%